Ligand Information
| Ligand General Information | Top | |||
|---|---|---|---|---|
| Ligand ID |
LC15MZ
|
|||
| Ligand Name |
N-(5-(1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyramide
|
|||
| Synonyms |
BMS-5; 1338247-35-0; LIMKi 3; N-(5-(1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyramide; BMS 5; LIMKI-3 (BMS-5); N-[5-[2-(2,6-dichlorophenyl)-5-(difluoromethyl)pyrazol-3-yl]-1,3-thiazol-2-yl]-2-methylpropanamide; BMS5; N-{5-[1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-1,3-thiazol-2-yl}-2-methylpropanamide; N-[5-[1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-2-methylpropanamide; C17H14Cl2F2N4OS; LIMKi3; LIMKi-3; LIM Kinase Inhibitor I; GTPL9839; CHEMBL2141887; SCHEMBL15543888; EX-A934; CHEBI:138670; DTXSID201113664; HMS3244I07; HMS3244I08; HMS3244J07; HMS3743I19; BCP17223; MFCD17019327; ZINC72232826; AKOS024458322; CS-5617; NCGC00263197-01; NCGC00263197-03; AC-35331; AS-16195; HY-18305; N-{5-[1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]- 1,3-thiazol-2-yl}-2-methylpropanamide; FT-0700442; S0185; EN300-115361; A888014; J-523083; LH0; Propanamide, N-[5-[1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-2-methyl-
Click to Show/Hide
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H14Cl2F2N4OS
|
|||
| Canonical SMILES |
CC(C)C(=O)NC1=NC=C(S1)C2=CC(=NN2C3=C(C=CC=C3Cl)Cl)C(F)F
|
|||
| InChI |
1S/C17H14Cl2F2N4OS/c1-8(2)16(26)23-17-22-7-13(27-17)12-6-11(15(20)21)24-25(12)14-9(18)4-3-5-10(14)19/h3-8,15H,1-2H3,(H,22,23,26)
|
|||
| InChIKey |
IVUGBSGLHRJSSP-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.